nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—Pulmonary eosinophilia—Dapsone—leprosy	0.0553	0.132	CcSEcCtD
Captopril—REN—arm—leprosy	0.0346	0.0601	CbGeAlD
Captopril—MMP2—hindlimb—leprosy	0.0333	0.0578	CbGeAlD
Captopril—REN—appendage—leprosy	0.0311	0.0539	CbGeAlD
Captopril—MMP9—hindlimb—leprosy	0.029	0.0503	CbGeAlD
Captopril—MMP2—appendage—leprosy	0.0286	0.0496	CbGeAlD
Captopril—REN—peripheral nervous system—leprosy	0.0283	0.0491	CbGeAlD
Captopril—F2—hindlimb—leprosy	0.0253	0.0439	CbGeAlD
Captopril—MMP9—appendage—leprosy	0.0248	0.0431	CbGeAlD
Captopril—MMP2—skin epidermis—leprosy	0.0238	0.0413	CbGeAlD
Captopril—REN—nerve—leprosy	0.022	0.0382	CbGeAlD
Captopril—F2—appendage—leprosy	0.0217	0.0376	CbGeAlD
Captopril—Nephrotic syndrome—Dapsone—leprosy	0.0209	0.0501	CcSEcCtD
Captopril—MMP9—skin epidermis—leprosy	0.0207	0.0359	CbGeAlD
Captopril—REN—blood vessel—leprosy	0.0173	0.03	CbGeAlD
Captopril—MMP2—blood vessel—leprosy	0.0159	0.0276	CbGeAlD
Captopril—ACE—hindlimb—leprosy	0.0154	0.0268	CbGeAlD
Captopril—ACE—arm—leprosy	0.0147	0.0256	CbGeAlD
Captopril—MMP9—blood vessel—leprosy	0.0138	0.024	CbGeAlD
Captopril—ACE—appendage—leprosy	0.0132	0.023	CbGeAlD
Captopril—Rales—Thalidomide—leprosy	0.0126	0.0302	CcSEcCtD
Captopril—F2—blood vessel—leprosy	0.0121	0.0209	CbGeAlD
Captopril—ACE—peripheral nervous system—leprosy	0.012	0.0209	CbGeAlD
Captopril—LTA4H—eye—leprosy	0.0119	0.0207	CbGeAlD
Captopril—Proteinuria—Dapsone—leprosy	0.0115	0.0275	CcSEcCtD
Captopril—Protein urine present—Dapsone—leprosy	0.0113	0.0272	CcSEcCtD
Captopril—Aphthous stomatitis—Thalidomide—leprosy	0.011	0.0264	CcSEcCtD
Captopril—ACE—nerve—leprosy	0.00939	0.0163	CbGeAlD
Captopril—MMP2—eye—leprosy	0.00846	0.0147	CbGeAlD
Captopril—Myasthenia—Thalidomide—leprosy	0.00823	0.0197	CcSEcCtD
Captopril—LTA4H—tendon—leprosy	0.0079	0.0137	CbGeAlD
Captopril—ACE—blood vessel—leprosy	0.00737	0.0128	CbGeAlD
Captopril—MMP2—skin of body—leprosy	0.00736	0.0128	CbGeAlD
Captopril—MMP9—eye—leprosy	0.00736	0.0128	CbGeAlD
Captopril—Cholestasis—Thalidomide—leprosy	0.00681	0.0163	CcSEcCtD
Captopril—LTA4H—testis—leprosy	0.00654	0.0114	CbGeAlD
Captopril—Muscular weakness—Dapsone—leprosy	0.00647	0.0155	CcSEcCtD
Captopril—F2—eye—leprosy	0.00642	0.0111	CbGeAlD
Captopril—LTA4H—nervous system—leprosy	0.00642	0.0111	CbGeAlD
Captopril—MMP9—skin of body—leprosy	0.0064	0.0111	CbGeAlD
Captopril—Pancreatitis—Dapsone—leprosy	0.00621	0.0149	CcSEcCtD
Captopril—Jaundice cholestatic—Thalidomide—leprosy	0.00589	0.0141	CcSEcCtD
Captopril—Proteinuria—Thalidomide—leprosy	0.00589	0.0141	CcSEcCtD
Captopril—Protein urine present—Thalidomide—leprosy	0.0058	0.0139	CcSEcCtD
Captopril—Photosensitivity reaction—Dapsone—leprosy	0.00578	0.0139	CcSEcCtD
Captopril—Oliguria—Thalidomide—leprosy	0.00561	0.0134	CcSEcCtD
Captopril—MMP2—tendon—leprosy	0.0056	0.00973	CbGeAlD
Captopril—Drug interaction—Thalidomide—leprosy	0.00557	0.0134	CcSEcCtD
Captopril—Hepatocellular injury—Thalidomide—leprosy	0.00517	0.0124	CcSEcCtD
Captopril—Hyperkalaemia—Thalidomide—leprosy	0.00508	0.0122	CcSEcCtD
Captopril—Pharyngitis—Dapsone—leprosy	0.00503	0.0121	CcSEcCtD
Captopril—REN—nervous system—leprosy	0.00496	0.0086	CbGeAlD
Captopril—MMP9—tendon—leprosy	0.00487	0.00846	CbGeAlD
Captopril—Dry eye—Thalidomide—leprosy	0.00478	0.0114	CcSEcCtD
Captopril—MMP2—testis—leprosy	0.00464	0.00806	CbGeAlD
Captopril—Gynaecomastia—Thalidomide—leprosy	0.00463	0.0111	CcSEcCtD
Captopril—MMP2—nervous system—leprosy	0.00455	0.00791	CbGeAlD
Captopril—Lymphadenopathy—Thalidomide—leprosy	0.0044	0.0105	CcSEcCtD
Captopril—Diabetes mellitus—Thalidomide—leprosy	0.00432	0.0103	CcSEcCtD
Captopril—Photosensitivity—Thalidomide—leprosy	0.00428	0.0102	CcSEcCtD
Captopril—Vision blurred—Dapsone—leprosy	0.00416	0.00997	CcSEcCtD
Captopril—Renal failure acute—Thalidomide—leprosy	0.00407	0.00974	CcSEcCtD
Captopril—MMP9—testis—leprosy	0.00404	0.00701	CbGeAlD
Captopril—Dermatitis exfoliative—Thalidomide—leprosy	0.00398	0.00953	CcSEcCtD
Captopril—MMP9—nervous system—leprosy	0.00396	0.00688	CbGeAlD
Captopril—Dermatitis bullous—Thalidomide—leprosy	0.00393	0.00941	CcSEcCtD
Captopril—ACE—eye—leprosy	0.00392	0.00681	CbGeAlD
Captopril—Cough—Dapsone—leprosy	0.00385	0.00923	CcSEcCtD
Captopril—Cerebrovascular accident—Thalidomide—leprosy	0.00383	0.00917	CcSEcCtD
Captopril—Hyponatraemia—Thalidomide—leprosy	0.00377	0.00903	CcSEcCtD
Captopril—Cardiac arrest—Thalidomide—leprosy	0.00357	0.00855	CcSEcCtD
Captopril—Ataxia—Thalidomide—leprosy	0.00353	0.00845	CcSEcCtD
Captopril—Tachycardia—Dapsone—leprosy	0.00352	0.00842	CcSEcCtD
Captopril—F2—nervous system—leprosy	0.00346	0.006	CbGeAlD
Captopril—Orthostatic hypotension—Thalidomide—leprosy	0.00343	0.00821	CcSEcCtD
Captopril—Muscular weakness—Thalidomide—leprosy	0.00331	0.00793	CcSEcCtD
Captopril—Insomnia—Dapsone—leprosy	0.00326	0.00781	CcSEcCtD
Captopril—Eosinophilia—Thalidomide—leprosy	0.00321	0.00769	CcSEcCtD
Captopril—Bronchospasm—Thalidomide—leprosy	0.00319	0.00764	CcSEcCtD
Captopril—Pancreatitis—Thalidomide—leprosy	0.00318	0.00762	CcSEcCtD
Captopril—Angina pectoris—Thalidomide—leprosy	0.00316	0.00757	CcSEcCtD
Captopril—Pancytopenia—Thalidomide—leprosy	0.00308	0.00738	CcSEcCtD
Captopril—Neutropenia—Thalidomide—leprosy	0.00303	0.00727	CcSEcCtD
Captopril—Pollakiuria—Thalidomide—leprosy	0.003	0.00718	CcSEcCtD
Captopril—Erectile dysfunction—Thalidomide—leprosy	0.00299	0.00716	CcSEcCtD
Captopril—Photosensitivity reaction—Thalidomide—leprosy	0.00296	0.00709	CcSEcCtD
Captopril—Gastrointestinal pain—Dapsone—leprosy	0.00295	0.00706	CcSEcCtD
Captopril—Weight decreased—Thalidomide—leprosy	0.00294	0.00703	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00287	0.00687	CcSEcCtD
Captopril—Abdominal pain—Dapsone—leprosy	0.00285	0.00682	CcSEcCtD
Captopril—Body temperature increased—Dapsone—leprosy	0.00285	0.00682	CcSEcCtD
Captopril—Renal failure—Thalidomide—leprosy	0.00284	0.00681	CcSEcCtD
Captopril—Stomatitis—Thalidomide—leprosy	0.00282	0.00675	CcSEcCtD
Captopril—Agranulocytosis—Thalidomide—leprosy	0.0027	0.00647	CcSEcCtD
Captopril—Rhinitis—Thalidomide—leprosy	0.0026	0.00624	CcSEcCtD
Captopril—Hepatitis—Thalidomide—leprosy	0.0026	0.00622	CcSEcCtD
Captopril—ABCB1—blood vessel—leprosy	0.0026	0.0045	CbGeAlD
Captopril—Pharyngitis—Thalidomide—leprosy	0.00258	0.00617	CcSEcCtD
Captopril—Erythema multiforme—Thalidomide—leprosy	0.00246	0.00588	CcSEcCtD
Captopril—Alopecia—Thalidomide—leprosy	0.00229	0.0055	CcSEcCtD
Captopril—Vomiting—Dapsone—leprosy	0.00229	0.00549	CcSEcCtD
Captopril—Headache—Dapsone—leprosy	0.00226	0.00541	CcSEcCtD
Captopril—ALB—testis—leprosy	0.00225	0.0039	CbGeAlD
Captopril—Tension—Thalidomide—leprosy	0.00222	0.00531	CcSEcCtD
Captopril—Dysgeusia—Thalidomide—leprosy	0.00221	0.0053	CcSEcCtD
Captopril—Nervousness—Thalidomide—leprosy	0.0022	0.00526	CcSEcCtD
Captopril—ACE—testis—leprosy	0.00215	0.00373	CbGeAlD
Captopril—Nausea—Dapsone—leprosy	0.00214	0.00513	CcSEcCtD
Captopril—Vision blurred—Thalidomide—leprosy	0.00213	0.0051	CcSEcCtD
Captopril—ACE—nervous system—leprosy	0.00211	0.00367	CbGeAlD
Captopril—Ill-defined disorder—Thalidomide—leprosy	0.0021	0.00502	CcSEcCtD
Captopril—Anaemia—Thalidomide—leprosy	0.00209	0.005	CcSEcCtD
Captopril—Angioedema—Thalidomide—leprosy	0.00207	0.00495	CcSEcCtD
Captopril—Malaise—Thalidomide—leprosy	0.00204	0.00488	CcSEcCtD
Captopril—Syncope—Thalidomide—leprosy	0.00203	0.00486	CcSEcCtD
Captopril—Palpitations—Thalidomide—leprosy	0.002	0.00478	CcSEcCtD
Captopril—Loss of consciousness—Thalidomide—leprosy	0.00199	0.00476	CcSEcCtD
Captopril—Cough—Thalidomide—leprosy	0.00197	0.00472	CcSEcCtD
Captopril—Myalgia—Thalidomide—leprosy	0.00192	0.00461	CcSEcCtD
Captopril—Arthralgia—Thalidomide—leprosy	0.00192	0.00461	CcSEcCtD
Captopril—Chest pain—Thalidomide—leprosy	0.00192	0.00461	CcSEcCtD
Captopril—Discomfort—Thalidomide—leprosy	0.0019	0.00455	CcSEcCtD
Captopril—Dry mouth—Thalidomide—leprosy	0.00188	0.00451	CcSEcCtD
Captopril—Confusional state—Thalidomide—leprosy	0.00186	0.00446	CcSEcCtD
Captopril—Shock—Thalidomide—leprosy	0.00182	0.00435	CcSEcCtD
Captopril—Thrombocytopenia—Thalidomide—leprosy	0.00181	0.00433	CcSEcCtD
Captopril—Tachycardia—Thalidomide—leprosy	0.0018	0.00431	CcSEcCtD
Captopril—Anorexia—Thalidomide—leprosy	0.00176	0.00421	CcSEcCtD
Captopril—Hypotension—Thalidomide—leprosy	0.00172	0.00413	CcSEcCtD
Captopril—Musculoskeletal discomfort—Thalidomide—leprosy	0.00168	0.00403	CcSEcCtD
Captopril—Insomnia—Thalidomide—leprosy	0.00167	0.004	CcSEcCtD
Captopril—Paraesthesia—Thalidomide—leprosy	0.00166	0.00397	CcSEcCtD
Captopril—Dyspnoea—Thalidomide—leprosy	0.00164	0.00394	CcSEcCtD
Captopril—Somnolence—Thalidomide—leprosy	0.00164	0.00393	CcSEcCtD
Captopril—Dyspepsia—Thalidomide—leprosy	0.00162	0.00389	CcSEcCtD
Captopril—Decreased appetite—Thalidomide—leprosy	0.0016	0.00384	CcSEcCtD
Captopril—Fatigue—Thalidomide—leprosy	0.00159	0.00381	CcSEcCtD
Captopril—Constipation—Thalidomide—leprosy	0.00158	0.00378	CcSEcCtD
Captopril—Feeling abnormal—Thalidomide—leprosy	0.00152	0.00364	CcSEcCtD
Captopril—Gastrointestinal pain—Thalidomide—leprosy	0.00151	0.00361	CcSEcCtD
Captopril—Abdominal pain—Thalidomide—leprosy	0.00146	0.00349	CcSEcCtD
Captopril—Body temperature increased—Thalidomide—leprosy	0.00146	0.00349	CcSEcCtD
Captopril—Asthenia—Thalidomide—leprosy	0.00132	0.00317	CcSEcCtD
Captopril—Pruritus—Thalidomide—leprosy	0.00131	0.00313	CcSEcCtD
Captopril—Diarrhoea—Thalidomide—leprosy	0.00126	0.00302	CcSEcCtD
Captopril—Dizziness—Thalidomide—leprosy	0.00122	0.00292	CcSEcCtD
Captopril—Vomiting—Thalidomide—leprosy	0.00117	0.00281	CcSEcCtD
Captopril—Rash—Thalidomide—leprosy	0.00116	0.00279	CcSEcCtD
Captopril—Dermatitis—Thalidomide—leprosy	0.00116	0.00278	CcSEcCtD
Captopril—Headache—Thalidomide—leprosy	0.00116	0.00277	CcSEcCtD
Captopril—Nausea—Thalidomide—leprosy	0.0011	0.00262	CcSEcCtD
Captopril—CYP2D6—testis—leprosy	0.00105	0.00183	CbGeAlD
Captopril—CYP2D6—nervous system—leprosy	0.00103	0.00179	CbGeAlD
Captopril—MMP9—IL1 and megakaryotyces in obesity—TLR1—leprosy	0.000997	0.156	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—TLR1—leprosy	0.00077	0.121	CbGpPWpGaD
Captopril—ABCB1—testis—leprosy	0.000757	0.00131	CbGeAlD
Captopril—ABCB1—nervous system—leprosy	0.000743	0.00129	CbGeAlD
Captopril—MMP9—IL1 and megakaryotyces in obesity—TLR2—leprosy	0.000508	0.0797	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—TLR2—leprosy	0.000392	0.0615	CbGpPWpGaD
Captopril—MMP9—IL1 and megakaryotyces in obesity—IFNG—leprosy	0.000229	0.0359	CbGpPWpGaD
Captopril—MMP2—Matrix Metalloproteinases—TNF—leprosy	0.000189	0.0296	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—TNF—leprosy	0.000179	0.0282	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—IFNG—leprosy	0.000177	0.0277	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—IFNG—leprosy	0.00017	0.0267	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL10—leprosy	0.000165	0.0259	CbGpPWpGaD
Captopril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000134	0.0211	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—leprosy	0.000126	0.0197	CbGpPWpGaD
Captopril—MMP9—Matrix Metalloproteinases—TNF—leprosy	0.000124	0.0194	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SDHD—leprosy	0.000122	0.0191	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—TNF—leprosy	0.000118	0.0185	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—HLA-DRB1—leprosy	0.000115	0.018	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IFNG—leprosy	9.72e-05	0.0153	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IFNG—leprosy	9.67e-05	0.0152	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—leprosy	9.47e-05	0.0149	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL2—leprosy	8.64e-05	0.0136	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	8.23e-05	0.0129	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CD4—leprosy	8.12e-05	0.0127	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IFNG—leprosy	7.87e-05	0.0123	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL2—leprosy	6.99e-05	0.011	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IFNG—leprosy	6.4e-05	0.01	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—leprosy	6.36e-05	0.00998	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—TNF—leprosy	6.26e-05	0.00982	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IFNG—leprosy	6.25e-05	0.00981	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	6.11e-05	0.00958	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL2—leprosy	5.69e-05	0.00893	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TNF—leprosy	5.09e-05	0.00799	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—leprosy	4.18e-05	0.00656	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TNF—leprosy	4.14e-05	0.0065	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—TNF—leprosy	4.05e-05	0.00635	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD40LG—leprosy	4.03e-05	0.00632	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—leprosy	4.03e-05	0.00632	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IFNG—leprosy	3.84e-05	0.00602	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	3.24e-05	0.00509	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC11A1—leprosy	3.17e-05	0.00498	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IFNG—leprosy	3.12e-05	0.0049	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	3.1e-05	0.00487	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—leprosy	2.78e-05	0.00435	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—leprosy	2.66e-05	0.00417	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—leprosy	2.48e-05	0.0039	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—leprosy	2.48e-05	0.00389	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—leprosy	2.37e-05	0.00372	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—leprosy	2.11e-05	0.0033	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—leprosy	2.02e-05	0.00317	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—leprosy	2.01e-05	0.00315	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	1.61e-05	0.00253	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—leprosy	1.61e-05	0.00252	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—leprosy	1.53e-05	0.00241	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RIPK2—leprosy	1.5e-05	0.00236	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.41e-05	0.00222	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—leprosy	1.37e-05	0.00215	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—leprosy	1.32e-05	0.00207	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RIPK2—leprosy	1.16e-05	0.00182	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	1.06e-05	0.00166	CbGpPWpGaD
Captopril—ALB—Metabolism—SDHD—leprosy	1.01e-05	0.00158	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SDHD—leprosy	8.81e-06	0.00138	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—leprosy	8.66e-06	0.00136	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SDHD—leprosy	8.3e-06	0.0013	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—leprosy	7.87e-06	0.00123	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	7.57e-06	0.00119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—leprosy	6.02e-06	0.000944	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—leprosy	5.44e-06	0.000853	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—leprosy	4.65e-06	0.000729	CbGpPWpGaD
